Your browser doesn't support javascript.
loading
Somatic loss of PIK3R1 may sensitize breast cancer to inhibitors of the MAPK pathway.
Turturro, Sanja B; Najor, Matthew S; Yung, Timothy; Portt, Liam; Malarkey, Christopher S; Abukhdeir, Abde M; Cobleigh, Melody A.
Afiliación
  • Turturro SB; Division of Hematology, Oncology, and Cell Therapy, Department of Internal Medicine, Rush University Medical Center, 1725 W. Harrison St., Chicago, IL, 60612, USA.
  • Najor MS; Division of Hematology, Oncology, and Cell Therapy, Department of Internal Medicine, Rush University Medical Center, 1725 W. Harrison St., Chicago, IL, 60612, USA.
  • Yung T; Division of Hematology, Oncology, and Cell Therapy, Department of Internal Medicine, Rush University Medical Center, 1725 W. Harrison St., Chicago, IL, 60612, USA.
  • Portt L; Division of Hematology, Oncology, and Cell Therapy, Department of Internal Medicine, Rush University Medical Center, 1725 W. Harrison St., Chicago, IL, 60612, USA.
  • Malarkey CS; School of Pharmacy, Rueckert-Hartman College for Health Professions, Regis University, 3333 Regis Boulevard, H-28, Denver, CO, 80221-1099, USA.
  • Abukhdeir AM; Division of Hematology, Oncology, and Cell Therapy, Department of Internal Medicine, Rush University Medical Center, 1725 W. Harrison St., Chicago, IL, 60612, USA. abde_abukhdeir@rush.edu.
  • Cobleigh MA; Division of Hematology, Oncology, and Cell Therapy, Department of Internal Medicine, Rush University Medical Center, 1725 W. Harrison St., Chicago, IL, 60612, USA.
Breast Cancer Res Treat ; 177(2): 325-333, 2019 Sep.
Article en En | MEDLINE | ID: mdl-31209687
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Resistencia a Antineoplásicos / Sistema de Señalización de MAP Quinasas / Inhibidores de Proteínas Quinasas / Fosfatidilinositol 3-Quinasa Clase Ia Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Resistencia a Antineoplásicos / Sistema de Señalización de MAP Quinasas / Inhibidores de Proteínas Quinasas / Fosfatidilinositol 3-Quinasa Clase Ia Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos